Drug intelligence / Profile preview

metahydroxylamine

Development stage
Phase 4
Lead developer
Fresenius Kabi
Modality
Small Molecules
Administration
Intramuscular, Intravenous, Subcutaneous
01

Overview

Metahydroxylamine (commonly used as the bitartrate salt) is a small molecule vasopressor agent primarily indicated for the prevention and treatment of acute hypotension during intraspinal (spinal or epidural) anesthesia. It is also used as adjunctive therapy for hypotension resulting from hemorrhage, drug allergy, surgical complications, brain trauma or tumor with shock, cardiogenic shock, and septicemia. The mechanism of action involves direct stimulation of alpha-adrenergic receptors leading to vasoconstriction and a sustained increase in both systolic and diastolic blood pressure. The effective enantiomer is the (1R,2S)-isomer. Metahydroxylamine bitartrate is marketed under the brand name Aramine in Australia and other countries[1][7][9].

Brand names
Aramine
Other names
m-hydroxylaminemeta-hydroxylamine bitartratem-hydroxylamine bitartratetartaric acid metahydroxylamine
02

Targets

ADRA1A (α1A)ADRA1 (Alpha-1 adrenergic receptor family)

Beyond the preview

Go deeper on metahydroxylamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metahydroxylamine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call